Hunan Warrants Pharmaceutical Co., Ltd. logo

Hunan Warrants Pharmaceutical Co., Ltd. (688799)

Market Closed
11 Aug, 06:57
SSE SSE
¥
46. 62
+0.43
+0.9309%
¥
3.79B Market Cap
- P/E Ratio
3.6% Div Yield
4.34M Volume
- Eps
¥ 46.19
Previous Close
Add Transaction
Day Range
44.43 48.3
Year Range
40.33 66.88
Want to track 688799 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688799 closed today higher at ¥46.62, an increase of 0.9309% from yesterday's close, completing a monthly increase of 4.576% or ¥2.04. Over the past 12 months, 688799 stock lost -2.1%.
688799 pays dividends to its shareholders, with the most recent payment made on Jul 01, 2026. The next estimated payment will be in In 10 months on Jul 01, 2027 for a total of ¥0.1788.
Hunan Warrants Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 29, 2025.
The company's stock is traded on one exchange.

688799 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Hunan Warrants Pharmaceutical Co., Ltd. (688799) FAQ

What is the stock price today?

The current price is ¥46.62.

On which exchange is it traded?

Hunan Warrants Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688799.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.6%.

What is its market cap?

As of today, the market cap is 3.79B.

Has Hunan Warrants Pharmaceutical Co., Ltd. ever had a stock split?

Hunan Warrants Pharmaceutical Co., Ltd. had 1 splits and the recent split was on May 29, 2025.

Hunan Warrants Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ben Dong Huang CEO
SSE Exchange
CNE100004P73 ISIN
CN Country
1,162 Employees
1 Jul 2026 Last Dividend
29 May 2025 Last Split
- IPO Date

Overview

Hunan Warrant Pharmaceutical Co.,Ltd is a prominent entity in the pharmaceutical industry, dedicated to manufacturing and distributing an array of pharmaceutical products. With its foundation laid in 2001, the company has anchored its position in Changsha, China, showcasing a significant commitment towards enhancing healthcare through its innovative solutions. The firm operates within a broad spectrum of therapeutic areas, including digestive health, respiratory conditions, infection control, women's health, cardiovascular and cerebrovascular health, immune system support, kidney function, and more, thereby addressing a wide range of medical needs and improving patient outcomes.

Products and Services

The product range offered by Hunan Warrant Pharmaceutical Co.,Ltd encompasses a variety of medicines designed to meet the healthcare needs in several key fields:

  • Digestive – This category includes medicines aimed at improving digestive health and treating disorders of the gastrointestinal tract.
  • Breathing – Products under this classification are formulated to address various respiratory conditions, aiding in easier breathing and lung function.
  • Anti-Infection – The company provides medications that help combat infectious diseases, geared towards limiting the spread of infections and treating their symptoms.
  • Gynecology – Focused on women's health, this area offers treatments and therapies for a wide range of gynecological issues.
  • Cardiovascular – Medicines in this category are designed to support heart health and treat conditions related to the cardiovascular system.
  • Cerebrovascular – This segment includes products aimed at improving brain health and treating cerebrovascular diseases to enhance cognitive functions and overall mental health.
  • Immunology – Immune system boosters and treatments for various immune-related illnesses fall under this category, ensuring a well-defended body against numerous pathogens.
  • Nephrology – Dedicated to kidney health, this section offers treatments for kidney-related diseases, helping in the management of renal function.

Through its comprehensive range of products and services, Hunan Warrant Pharmaceutical Co.,Ltd is committed to advancing healthcare standards and providing effective solutions for an extensive array of medical conditions, thereby contributing to the well-being of communities worldwide.

Contact Information

Address: Building C6-C7, Changsha, China, 410006
Phone: 86 73 1859 10593